Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Learn essential ways to get started in real estate investing, paving your path to financial independence. Begin your investment journey today.
23,306 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
With oil prices near a year high, IEO’s $0.55 quarterly dividend is set to be tested by producer payouts and market s...
Tuesday’s market action centers on fresh analyst calls for Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Ve...
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
A dramatic one-month move put Rubrik in the spotlight. This article breaks down what happened, why it matters, and ho...
A 66-year-old HSA holder faces $7,800 in excess contributions penalties tied to the six-month Medicare lookback. The ...
Investors face a pivotal choice in 2026: M/I Homes versus Champion Homes. This guide breaks down how each builder ear...
A record-breaking bid for SpaceX could reshape the opening trading landscape. Here’s how inflows of demand influence ...
As of 2026, the municipal bond market remains a steady source of funding for public projects and a tax-efficient inco...
As Meta Platforms advances a sweeping AI infrastructure plan, the stock remains a focus for investors who see the com...
May data shows a retail sales surge 0.9%, the strongest in three months, signaling resilience in consumer spending an...